• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 4
  3. Author

Online ISSN: 2515-8260

Volume8, Issue4

ASSESSMENT OF THE SEVERE ANAEMIA PREVALENCE AND ASSOCIATED FETO-MATERNAL OUTCOMES IN FEMALES ADMITTED FOR LABOR: A PROSPECTIVE CLINICAL STUDY

    Dr Apurva Tiwari, Dr.Sangeeta Patre

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 4, Pages 2367-2372

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: There exists a high prevalence of anaemia in pregnant females owing to
multiparity, close birth spacing, lack of appropriate antenatal care, low socioeconomic status,
ignorance, and illiteracy.
Objectives: The present study was conducted to assess the incidence of severe anaemia with
having hemoglobin of less than7gm% in pregnant females and to assess the fetal outcomes
following delivery in females having severe anaemia.
Methodology: A total of 1000 pregnant subjects were screened for anaemia. The pregnant
femaleshavingHb% of <7g% in labor were included and feto-maternal outcomes in these
females were evaluated.
Results: Puerperal complications seen were wound gaping, episiotomy, lactation failure, sub
involution, sepsis, and pyrexia in 2.46% (n=2), 2.46% (n=2), 8.64% (n=7), 7.40% (n=6),
2.46% (n=2), and 7.40% (n=6) subjects respectively in severe anaemia group, and in 12.12%
(n=4), 3.03% (n=1), 15.15% (n=5), 18.18% (n=6), 6.06% (n=2), and 9.09% (n=3) subjects
respectively with very severe anaemia. Mortality was seen in 3.03% (n=1) subject with very
severe anaemia. Morbidity was seen in 27.16% (n=22) subjects with severe anaemia and in
45.45% (n=15) subjects with very severe anaemia. The fetal outcomes were also evaluated in
the study subjects. Low birth weight was seen in 7.40% (n=6) subjects with severe anaemia
and in 6.06% (n=2) subjects with very severe anaemia. Neonatal mortality and morbidity was
seen in 1.23% (n=1) and 13.58% (n=11) subjects respectively with severe anaemia, and in
6.06% (n=2) and 24.24% (n=8) subjects respectively with very severe anaemia. Fetal
complications seen in the present study were birthaplasia in 1.23% (n=1) and 3.03% (n=1)
subject with severe and very severe anaemia respectively, sepsis in 1.23% (n=1) and 3.03%
(n=1) subject with severe and very severe anaemia respectively, and IUGR in 1.23% (n=1)
subject with severe anaemia.
Keywords:
    Anaemia Maternal Deaths multigravida neonatal morbidity Preterm low-birth
  • PDF (262 K)
  • XML
(2022). ASSESSMENT OF THE SEVERE ANAEMIA PREVALENCE AND ASSOCIATED FETO-MATERNAL OUTCOMES IN FEMALES ADMITTED FOR LABOR: A PROSPECTIVE CLINICAL STUDY. European Journal of Molecular & Clinical Medicine, 8(4), 2367-2372.
Dr Apurva Tiwari, Dr.Sangeeta Patre. "ASSESSMENT OF THE SEVERE ANAEMIA PREVALENCE AND ASSOCIATED FETO-MATERNAL OUTCOMES IN FEMALES ADMITTED FOR LABOR: A PROSPECTIVE CLINICAL STUDY". European Journal of Molecular & Clinical Medicine, 8, 4, 2022, 2367-2372.
(2022). 'ASSESSMENT OF THE SEVERE ANAEMIA PREVALENCE AND ASSOCIATED FETO-MATERNAL OUTCOMES IN FEMALES ADMITTED FOR LABOR: A PROSPECTIVE CLINICAL STUDY', European Journal of Molecular & Clinical Medicine, 8(4), pp. 2367-2372.
ASSESSMENT OF THE SEVERE ANAEMIA PREVALENCE AND ASSOCIATED FETO-MATERNAL OUTCOMES IN FEMALES ADMITTED FOR LABOR: A PROSPECTIVE CLINICAL STUDY. European Journal of Molecular & Clinical Medicine, 2022; 8(4): 2367-2372.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 133
  • PDF Download: 127
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus